Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome
- Paul G. Murray
- , David Lissauer
- , Jia Junying
- , Gillian Davies
- , Sukhjinder Moore
- , Andrew Bell
- , Judith Timms
- , David Rowlands
- , Christopher McConkey
- , Gary M. Reynolds
- , Suk Ghataura
- , David England
- , Rebecca Caroll
- , Lawrence S. Young
- University of Birmingham
Research output: Contribution to journal › Article › peer-review